Clinical Updates

For 25 years, researchers have tried and failed to develop an HIV vaccine, primarily by focusing on a small… »   

A study of Pfizer Inc’s Sutent was halted early after the medicine delayed progression of a rare form of pancreatic… »   

Rutgers AIDS researchers Gail Ferstandig Arnold and Eddy Arnold may have turned a corner in their search for a HIV… »   

Current treatments for membranous nephropathy are limited to steroids, calcineurin inhibitors, and chemotherapeutic agents, all of which have significant side… »   

Family nurse practitioners need to be more aware of the commercial pressures they face as a result of their increased… »   

Administration of a tissue-cultured smallpox vaccine showed signs of an effective vaccine response with no serious adverse events, according to… »   

A new study has found for the first time that maintenance therapy with the novel antibody, rituximab (MR) following cyclophosphamide,… »   

A recent study of 20 people suffering from lupus nephritis, a severe kidney disorder, who were all high risk… »   

A patch that slowly delivers nicotine, pain medication or other drug through the skin can cause a skin burn resembling… »   

The blockbuster cancer drug Rituxan, or MabThera, can significantly reduce kidney inflammation in some people with lupus who do not… »   

Pregnant women given drugs to prevent the baby being born too soon may run the risk of having serious… »   

A doctoral thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden, shows that it is possible to describe and… »   

Treatment with the targeted drug rituximab can significantly benefit some patients with severe lupus nephritis who do not respond to… »   

A recent study in Oregon suggests that drugs designed for treating the most severe mental illnesses are often prescribed at… »   

Achieving effective, durable, and safe pain relief, especially in patients with chronic and/or severe pain conditions, can be difficult. For… »